Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Honglei Zhou
Observed names:
Hong-Lei Zhou,
Hong-lei Zhou
Institution:
Shandong University of Traditional Chinese Medicine
Observed institutions:
St. Jude Children's Research Hospital,
Shandong University of Traditional Chinese Medicine,
Jiangsu Province Hospital,
Nanjing Medical University
ORCID:
0000-0002-8477-7153
Observed ORCID:
0000-0002-8477-7153
OpenAlex ID:
A5060142203
Systemic Administration of Neurotransmitter‐Derived Lipidoids‐PROTACs‐DNA Nanocomplex Promotes Tau Clearance and Cognitive Recovery for Alzheimer's Disease Therapy
2024
·
Baofeng Gong
, Weicong Zhang
, et al.
·
Advanced Healthcare Materials
·
44
PUS1 is a novel biomarker for predicting poor outcomes and triple-negative status in breast cancer
2022
·
Zheng Fang
, Hong-yu Shen
, et al.
·
Frontiers in Oncology
·
14
PDF
IFI30 as a key regulator of PDL1 immunotherapy prognosis in breast cancer
2024
·
Lei Li
, Yinjiao Fei
, et al.
·
International Immunopharmacology
·
13
Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer
2022
·
Zheng Fang
, Yu-Xin Song
, et al.
·
Annals of Translational Medicine
·
11
PDF
Androgen receptor expression and clinical characteristics in breast cancer
2024
·
Dan-dan Wang
, Lin-hong Jiang
, et al.
·
World Journal of Surgical Oncology
·
7
PDF
Integrative analysis of the role of BOLA2B in human pan-cancer
2023
·
Mingxing Liang
, Yinjiao Fei
, et al.
·
Frontiers in Genetics
·
5
Advances of HDAC dual inhibitors in breast cancer treatment
2025
·
Chuanjiang Wu
, Jiyong Wu
, et al.
·
Bioorganic & Medicinal Chemistry
·
4
Lysionotin nanoparticles ameliorate ethanol-elicited liver damage by inhibiting hepatocyte ferroptosis and modulating the gut-liver axis
2026
·
Fang-Fang Guo
, Shuo Wang
, et al.
·
International Immunopharmacology
·
2
TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2+ breast cancer
2024
·
Xinyi Shao
, Dawei Yang
, et al.
·
Archives of Toxicology
·
2
Hidden-driver inference reveals synergistic brain-penetrant therapies for medulloblastoma
2025
·
Jingjing Liu
, Xu Yang
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Systemic Administration of Neurotransmitter‐Derived Lipidoids‐PROTACs‐DNA Nanocomplex Promotes Tau Clearance and Cognitive Recovery for Alzheimer's Disease Therapy (Adv. Healthcare Mater. 32/2024)
2024
·
Baofeng Gong
, Weicong Zhang
, et al.
·
Advanced Healthcare Materials
PDF
Show more works
View as search
Works count:
11
Citation count:
102
H-index:
5
I10-index:
4
Year
Topic
Type